Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 13811-709

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 13811-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trigen Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methylphenidate Hydrochloride Extended Release Tab 1)

FDA Label Image

Methylphenidate54mg100ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 10)

Each tablet contains 54 mg of methylphenidate hydrochloride, USP which is an extended-release medication. The usual dosage information is available through accompanying prescribing information. It needs to be stored in tight containers, protected from moisture and humidity, and kept out of reach of children at a controlled room temperature of 20° to 25°C. It is manufactured by Trigen Laboratories, LLC, and the medication guide is provided separately to each patient. The product has 100 Tablets and GTIN 00313811709100.*

FDA Label Image

Methylphenidate72mg100ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 11)

Each tablet of this medication contains 72 mg of methylphenidate hydrochloride, USP. The usual dosage information can be found in the prescribing information. The tablets should be stored in a dry and cool place between 20°C to 25°C (68°F to 77°F), protected from moisture. The medication should be dispensed in tightly sealed containers, and kept out of reach of children. The tablets are an extended-release formula and have an NDC of 13811-710-10. Pharmacists should dispense the medication guide provided separately to each patient. Manufactured for Trigen Laboratories, LLC.*

FDA Label Image

Methylphenidate72mg30ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 12)

Each tablet is a extended-release formulation of 72mg of methylphenidate hydrochloride, USP. The tablets are to be stored at controlled room temperature and are intended for prescription use only. The medication is dispensed with an accompanying medication guide and should be kept out of reach of children. This is a generic medication distributed by Trigen Laboratories with NDC 13811-710-30.*

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

This is a table displaying the mean plasma methylphenidate concentration (in ng/mL) for two different medication regimens: Methylphenidate HCI extended-release tablets 18mg once daily and Methylphenidate 5mg three times daily. The concentrations are shown at different time points (16, 20, 24, 28, and 32).*

FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

FDA Label Image

Trigenlogo1_thumb10 (Methylphenidate Hydrochloride Extended Release Tab 5)

FDA Label Image

Trigen Logo (Methylphenidate Hydrochloride Extended Release Tab 6)

FDA Label Image

Methylphenidate18mg100ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 7)

This is a description of Methylphenidate Hydrochloride USP tablets for oral use. Each tablet contains 18 mg of medication. The usual dosage information is not provided and should be obtained from the prescribing information. The tablets should be stored in a controlled room temperature, protecting them from moisture and humidity, and kept in tight containers. The medication is manufactured by Trigen Laboratories, LLC in Alpharetta, Georgia, and is available in packs of 100 tablets. A medication guide should be provided to each patient, and the product should be kept out of reach of children. GTIN number is 00313811706109.*

FDA Label Image

Methylphenidate27mg100ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 8)

Each tablet of this medication contains 27 mg of methylphenidate hydrochloride, USP. The usual dosage and other important information are advised to be checked from the accompanying prescribing information. The medication should be stored at a temperature between 20° to 25°C (68° to 77°F), in tight containers, protected from moisture and humidity. This medication is for extended-release and intended to keep out of children's reach. The medication guide needs to be dispensed separately to each patient. It contains 100 tablets, with NDC 13811-707-10 and GTIN 00313811707106, and manufactured by L [TRIGEM, available at www.frigenlab.com.*

FDA Label Image

Methylphenidate36mg100ctrev022019 (Methylphenidate Hydrochloride Extended Release Tab 9)

Each tablet contains 36 mg of methylphenidate hydrochloride, USP. The usual dosage is recommended as per prescribing information. The tablets should be stored between 20° to 25°C (68° to 77°F) and protected from moisture and humidity. It is advised to keep the tablets in tight containers and out of reach of children. They are manufactured by Trigen Laboratories, LLC and come in a bottle of 100 tablets, which is available by prescription only. Pharmacists are to dispense the medication guide separately to each patient. Visit www.trigenlab.com for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.